Join
Live feed
·
INSIDERFilingvia Quantisnow
Global Blood Therapeutics Inc. logo

SEC Form 4: Johnson David Lee was granted 365 shares, converted options into 4,971 shares and covered exercise/tax liability with 2,103 shares, increasing direct ownership by 6% to 56,384 units (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GBT (Global Blood Therapeutics Inc.) and more on Quantisnow.